Literature DB >> 4057425

Role of natural killer activity in development of spontaneous metastases in murine renal cancer.

R R Salup, R B Herberman, R H Wiltrout.   

Abstract

We have studied the role of natural killer activity during the growth and dissemination of a transplantable renal adenocarcinoma (Renca) of spontaneous origin in BALB/c mice. The pattern of growth of this tumor accurately mimics that of adult human renal cell carcinoma in terms of clinical stages I-IV, particularly with regard to spontaneous metastasis to lung and liver. Renca is moderately sensitive to lysis by natural killer cells from normal mice and is more efficiently lysed by natural killer cells from mice treated with the biological response modifier maleic anhydride divinyl ether, a pyran copolymer. Our studies demonstrate that selective depression of natural killer activity by administration of antiserum specific for the neutral glycosphingolipid asialo GM1 correlated with increased formation of spontaneous metastases in the lungs, liver, and lymph nodes. Conversely, augmentation of natural killer activity by the biological response modifier decreased the formation of spontaneous metastases in lungs, liver and lymph nodes. Further, the suppression of natural killer activity and subsequent increased formation of metastases were accompanied by a significantly reduced survival time, whereas the augmented natural killer activity and decreased incidence of metastases in biological response modifier-treated mice were accompanied by an increase in time of survival. These results demonstrate a significant role for natural killer cells in the control of spontaneous metastasis during growth of this murine renal cancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4057425     DOI: 10.1016/s0022-5347(17)47702-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Fibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect.

Authors:  Dan Liu; Peter J Hornsby
Journal:  Neoplasia       Date:  2007-05       Impact factor: 5.715

2.  Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.

Authors:  Suliman Y Alomar; Afrah Alkhuriji; Paul Trayhyrn; Abdulkarim Alhetheel; Abdullah Al-Jurayyan; Lamjed Mansour
Journal:  Immunogenetics       Date:  2016-09-15       Impact factor: 2.846

3.  Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases.

Authors:  Hao Yin; Matthew J Frontini; John-Michael Arpino; Zengxuan Nong; Caroline O'Neil; Yiwen Xu; Brittany Balint; Aaron D Ward; Subrata Chakrabarti; Christopher G Ellis; Robert Gros; J Geoffrey Pickering
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

4.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice [corrected].

Authors:  I J Fidler; S Naito; S Pathak
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

Review 6.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

7.  Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.

Authors:  K Sonouchi; T A Hamilton; C S Tannenbaum; R R Tubbs; R Bukowski; J H Finke
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362.

Authors:  T Utsugi; C P Dinney; J J Killion; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.

Authors:  R R Salup; R H Wiltrout
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma.

Authors:  T Fujioka; K Ishikura; M Hasegawa; K Ogyu; Y Matsushita; M Sato; F Sato; H Aoki; T Kubo
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.